 |
|
When should children infected with HIV start medication
March 25, 2008When should children with HIV infection be started on anti-HIV medications?
The advent of effective medications for treating HIV dramatically improved the outlook for both adults and children infected with HIV who had access to treatment, but the optimal timing for starting treatment remains controversial, particularly in children. A debate article in this week's PLoS Medicine lays out the case for deferred treatment against the case for early initiation of treatment in children infected with HIV.
In laying out the case for deferred treatment, Dr Steven Welch (Consultant in Paediatric HIV and Infectious Diseases, Heartlands Hospital, Birmingham, UK) says that, "it remains rational to consider an individual child's and family's wishes and circumstances as well as the child's risk of disease progression in deciding when to start treatment." The hasty and injudicious use of antiretroviral medications in children, he argues, risks creating a cohort that has learned poor adherence habits, is infected with multi-drug-resistant viruses, and has been exposed to unnecessary cumulative drug toxicities.
Arguing the case for early initiation, Professor Di Gibb (Professor in Epidemiology and a Consultant Paediatrician at the Medical Research Council Clinical Trials Unit, London, UK), says that "deferring treatment initiation for as long as possible is no longer an option." Professor Gibb lays out several reasons why she believes that early initiation is even more important in children than in adults-for example, children with HIV grow better if they receive antiretroviral medication.
Both authors point out that there has never been a clinical trial conducted on determining when to start antiretroviral medications in children, and they conclude by saying that the time has come to conduct such a trial.
Citation: Welch SB, Gibb D (2008) When should children with HIV infection be started on antiretroviral therapy" PLoS Med 5(3): e73.
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050073
Public Library of Science
Arguing the case for early initiation, Professor Di Gibb (Professor in Epidemiology and a Consultant Paediatrician at the Medical Research Council Clinical Trials Unit, London, UK), says that "deferring treatment initiation for as long as possible is no longer an option." Professor Gibb lays out several reasons why she believes that early initiation is even more important in children than in adults-for example, children with HIV grow better if they receive antiretroviral medication.
Both authors point out that there has never been a clinical trial conducted on determining when to start antiretroviral medications in children, and they conclude by saying that the time has come to conduct such a trial.
Citation: Welch SB, Gibb D (2008) When should children with HIV infection be started on antiretroviral therapy" PLoS Med 5(3): e73.
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050073
Public Library of Science
HIV News and Current HIV Events RSSRisk of fracture is significantly higher in HIV-infected patients
As antiviral treatment for HIV infection allows patients to live longer, many will be confronted with additional health challenges. A new study shows for the first time that one of these may be significantly increased risk of bone fractures.
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily challenging properties of the virus that have made a vaccine elusive and outline the scientific questions that, if answered, could lead to an effective HIV vaccine.
Study reveals gap in HIV testing knowledge among college students
Most college students understand how they can prevent the transmission of HIV but are less knowledgeable about HIV testing, according to a new University of Georgia study.
Iowa State University researcher shows proteins have controlled motions
Iowa State University researcher Robert Jernigan believes that his research shows proteins have controlled motions.
HIV patients at greater risk for bone fractures
HIV-infected patients have a higher prevalence of fractures than non HIV-infected patients, across both genders and critical fracture sites according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
ABC-transporters expressed on endothelial cell membranes efflux anti-HIV drugs
Researchers at Tulane University Medical Center in New Orleans (USA) have discovered that drug-efflux pumps, belonging to the ATP-binding cassette (ABC) transporter family, are constitutively expressed on vascular endothelial cells.
Hospice and palliative medicine specialty strives to prepare physicians for aging baby boomers
The American Academy of Hospice and Palliative Medicine announces two important medical education courses in hospice and palliative medicine and a significantly revised book series in keeping with the Academy's ongoing commitment to prevent and relieve pain and suffering during serious illness.
Operations research promises continued gains for HIV treatment in resource-limited countries
In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it.
Personalized immunotherapy to fight HIV/AIDS
For a long time, the main obstacle to creating an AIDS vaccine has been the high genetic variability of the HIV virus. Dr. Jean-Pierre Routy and his team from the Research Institute of the McGill University Health Centre (MUHC), in collaboration with Dr. Rafick Sékaly from the Université de Montréal, have overcome this difficulty by designing a personalized immunotherapy for HIV-infected patients.
Caltech engineers build mini drug-producing biofactories in yeast
Researchers at the California Institute of Technology have developed a novel way to churn out large quantities of drugs, including antiplaque toothpaste additives, antibiotics, nicotine, and even morphine, using mini biofactories--in yeast.
More HIV News Articles
 | The Naked Truth: Young, Beautiful, and (HIV) Positive by Marvelyn Brown, Courtney Martin The surprisingly hopeful story of how a straight, nonpromiscuous, everyday girl contracted HIV and how she manages to stay upbeat, inspired, and more positive about life than ever before At nineteen years of age, Marvelyn Brown was lying in a stark white hospital bed at Tennessee Christian Medical Center, feeling hopeless. A former top track and basketball athlete, she was in the best shape of... |
 | There Is No Me Without You: One Woman's Odyssey to Rescue Her Country's Children by Melissa Fay Greene Two-time National Book Award nominee Melissa Fay Greene puts a human face on the African AIDS crisis with this powerful story of one woman working to save her country’s children. After losing her husband and daughter, Haregewoin Teferra, an Ethiopian woman of modest means, opened her home to some of the thousands of children in Addis Ababa who have been left as orphans. There Is No Me... |
 | AIDS Update 2008 (Aids Update) by Gerald J Stine AIDS Update 2008 presents a balanced review of current research and information on HIV infection, HIV disease, and AIDS. AIDS Update 2008 places this discussion within a biological, medical, social, economic and legal framework, helping readers to more fully understand this modern-day... |
 | The Invisible Cure: Why We Are Losing the Fight Against AIDS in Africa by Helen Epstein A New York Times Notable Book of 2007 The Invisible Cure is an account of Africa's AIDS epidemic from the inside--a revelatory dispatch from the intersection of village life, government intervention, and international aid. Helen Epstein left her job in the US in 1993 to move to Uganda, where she began work on a test vaccine for HIV. Once there, she met patients, doctors, politicians, and aid... |
 | On the Move by Bono |
 | The Wisdom of Whores: Bureaucrats, Brothels, and the Business of AIDS by Elizabeth Pisani A flame-throwing epidemiologist talks about sex, drugs, and the mistakes (dismal), ideologies (vicious), and hopes (realistic) of international AIDS prevention.When people ask Elizabeth Pisani what she does for a living, she says, "sex and drugs." As an epidemiologist researching AIDS, she's been involved with international efforts to halt the disease for fourteen years. With swashbuckling wit... |
 | And the Band Played On: Politics, People, and the AIDS Epidemic, 20th-Anniversary Edition by Randy Shilts In the first major book on AIDS, San Francisco Chronicle reporter Randy Shilts examines the making of an epidemic. Shilts researched and reported the book exhaustively, chronicling almost day-by-day the first five years of AIDS. His work is critical of the medical and scientific communities' initial response and particularly harsh on the Reagan Administration, who he claims cut funding, ignored... |
 | Illness as Metaphor and AIDS and Its Metaphors by Susan Sontag In 1978 Susan Sontag wrote Illness as Metaphor, a classic work described by Newsweek as "one of the most liberating books of its time." A cancer patient herself when she was writing the book, Sontag shows how the metaphors and myths surrounding certain illnesses, especially cancer, add greatly to the suffering of patients and often inhibit them from seeking proper treatment. By demystifying the... |
 | My Own Country: A Doctor's Story by Abraham Verghese Nestled in the Smoky Mountains of eastern Tennessee, the town of Johnson City saw its first AIDS patient in August 1985. Working in Johnson City was Abraham Verghese, a young Indian doctor specializing in infectious diseases who became, by necessity, the local AIDS expert. Out of his experience comes a startling, ultimately uplifting portrait of the American... |
 | We Are All the Same: A Story of a Boy's Courage and a Mother's Love by Jim Wooten Award-winning correspondent for ABC World News and Nightline Jim Wooten is a seasoned newsman who has covered tragedy the world over. Now he tells the story of Nkosi Johnson, an eleven-year-old South African boy born with AIDS into poverty in a shantytown and given only a few years to live. But his ailing mother managed to cross her country’s divisions of race and class to bring him to Gail... |
| © 2008 BrightSurf.com |